Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study
Multiple Sclerosis and Related Disorders（2021）
关键词
Relapsing multiple sclerosis,Evobrutinib,Cerebrospinal fluid,Bruton's tyrosine kinase,Phase 2,Central nervous system
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要